ATNX Stock Price, News & Analysis
Company Description
ATNX (NASDAQ: ATNX) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.3M.
ATNX stock has declined 98.0% over the past year.
This page provides a comprehensive overview of ATNX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ATNX (ATNX) stock. Over the past 12 months, the stock has lost 98.0%. At a market capitalization of $2.3M, ATNX is classified as a micro-cap stock with approximately 8.7M shares outstanding.
Latest News
ATNX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, stock split, conferences. View all ATNX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATNX Company Profile & Sector Positioning
ATNX (ATNX) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ATNX often look at related companies in the same sector, including (CADMD), Mallinckrodt Plc (MNKKQ), (CADMF), CHINA INFRASTRUCTURE CONSTRUCTI (CHNC), and Vencanna Ventures (TPPRF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATNX's relative position within its industry.